- Home
- ARVN
ARVN
Arvinas Inc.
as of 02-06-2026 4:00pm EST
Arvinas Inc is a United States-based biopharmaceutical company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development and commercialization of therapies that degrade disease-causing proteins.. The company's proprietary Proteolysis-Targeting Chimera (PROTAC), work by inducing the cell's own ubiquitin-proteasome system to target, degrade and remove disease-causing proteins. The group's product candidates are bavdegalutamide, ARV-471 and ARV-766.
Upcoming Earnings Alert:
Get ready for potential market movements as Arvinas Inc. (ARVN) prepares to release earnings report on 11 Feb 2026.
| Founded: | 2015 | Country: | United States |
| Employees: | N/A | City: | NEW HAVEN |
| Market Cap: | 781.0M | IPO Year: | 2018 |
| Target Price: | $18.14 | AVG Volume (30 days): | 753.9K |
| Analyst Decision: | Buy | Number of Analysts: | 23 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.81 | EPS Growth: | N/A |
| 52 Week Low/High: | $5.90 - $20.38 | Next Earning Date: | 02-11-2026 |
| Revenue: | $312,300,000 | Revenue Growth: | 93.86% |
| Revenue Growth (this year): | 10.55% | Revenue Growth (next year): | -68.06% |
| P/E Ratio: | N/A | Index: | N/A |
| Free Cash Flow: | -329500000.0 | FCF Growth: | N/A |
Compare ARVN vs Leading Stocks
See how ARVN stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "ARVN Arvinas Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.